American Business Times
SEE OTHER BRANDS

The best business and economy news from the United States

American Business Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.

Press releases published on June 10, 2025

Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer

Vivex® Biologics, Inc. Appoints Industry Veteran Jon E. Block, Ph.D., as Chief Clinical Officer

MIAMI, June 10, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the appointment of Jon E. Block, Ph.D., an industry luminary with more than 40 years of leadership experience in …

Academy Sports + Outdoors Reports First Quarter Fiscal 2025 Results

Academy Sports + Outdoors Reports First Quarter Fiscal 2025 Results

First Quarter Sales Decline (0.9)%; Comparable Sales Declined (3.7)% eCommerce Sales Increase 10.2%; New Stores Continue to Comp Positive Low Single Digits First Quarter Diluted GAAP EPS of $0.68; Returned $108M to Shareholders through Share Buy Backs and …

American Tungsten Corp. Identified Multiple Exploration Targets at Ima Mine & Provides an Update on its Technical Report

American Tungsten Corp. Identified Multiple Exploration Targets at Ima Mine & Provides an Update on its Technical Report

Vancouver, BC, June 10, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to provide an update on its exploration plans and independent technical report (the “Technical …

HPQ, Novacium, and Pragma Industries Sign Agreement for Commercial and Industrial Green Hydrogen Production Using METAGENE™ Technology

HPQ, Novacium, and Pragma Industries Sign Agreement for Commercial and Industrial Green Hydrogen Production Using METAGENE™ Technology

MONTREAL and LYON, France, June 10, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company driving innovation in advanced materials and critical process development, and its French …

HPQ Silicium, Novacium et Pragma Industries concluent un accord de coopération industrielle et commerciale pour la production d’hydrogène vert à l’aide de la technologie METAGENE™

HPQ Silicium, Novacium et Pragma Industries concluent un accord de coopération industrielle et commerciale pour la production d’hydrogène vert à l’aide de la technologie METAGENE™

MONTRÉAL et LYON, France, 10 juin 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’innovation en matériaux avancés et dans la mise au point de …

Bitget Lists BSquared Network (B2) in the Innovation and Public Chain Zone

Bitget Lists BSquared Network (B2) in the Innovation and Public Chain Zone

Victoria, Seychelles, June 10th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of BSquared Network (B2), an EVM-compatible Bitcoin Layer 2 solution. Trading for B2/USDT will commence on 10 June 2025 …

Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease

Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease

Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease AstraZeneca exercises option to license the first candidate from the IBD joint research program for further development and commercialization …

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement

MacroGenics received $70 million upfront cash payment from Sagard Healthcare Partners (Sagard) MacroGenics’ cash runway extended through first half of 2027 ROCKVILLE, MD, June 10, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage …

Skyharbour Intersects High-Grade Uranium in Significant 42 m Step Out Hole ML24-15 which Returned 4.74% U3O8 over 1.5 m within 6.4 m of 1.50% U3O8 at Moore Project

Skyharbour Intersects High-Grade Uranium in Significant 42 m Step Out Hole ML24-15 which Returned 4.74% U3O8 over 1.5 m within 6.4 m of 1.50% U3O8 at Moore Project

Vancouver, BC , June 10, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce the remaining assay results from its late 2024 diamond drilling program at its 100% owned, 35, …

Brunswick Exploration Once More Outlines a New, Major Dyke at Mirage

Brunswick Exploration Once More Outlines a New, Major Dyke at Mirage

MONTREAL, June 10, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; “BRW” or the “Company”) is pleased to report a further six drill results from the Winter 2025 program at its Mirage Project. The Mirage Project is located in …

Bitget to List Resolv (RESOLV) in the Innovation Zone

Bitget to List Resolv (RESOLV) in the Innovation Zone

Victoria, Seychelles, June 10th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced its Resolv (RESOLV) in its Innovation Zone. This listing supports the growing demand for stablecoin infrastructure backed by major …

Bitget Lists MEET48 (IDOL) for Spot Trading

Bitget Lists MEET48 (IDOL) for Spot Trading

Victoria, Seychelles, June 10th, 2025, Chainwire Bitget, the leading cryptocurrency exchange and Web3 company, has announced the listing of MEET48 (IDOL), adding it to spot trading. MEET48 integrates web3 and AI to foster the UGC model in the virtual idol …

Pharvaris Announces Annual Meeting of Shareholders

Pharvaris Announces Annual Meeting of Shareholders

ZUG, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases …

Nathan's Famous, Inc. Reports Year End And Fourth Quarter Results

Nathan's Famous, Inc. Reports Year End And Fourth Quarter Results

JERICHO, N.Y., June 10, 2025 (GLOBE NEWSWIRE) -- Nathan's Famous, Inc. (“Nathan’s”, the “Company”, “we”, “us” or “our”) (NASDAQ:NATH) today reported results for its fiscal year and fourth quarter ended March 30, 2025. Effective June 10, 2025, the Board of …

Hyperscale Data Subsidiary Sentinum Signs Hosting Agreement to Expand its Bitcoin Mining and Participate in Energy Curtailment Program

Hyperscale Data Subsidiary Sentinum Signs Hosting Agreement to Expand its Bitcoin Mining and Participate in Energy Curtailment Program

LAS VEGAS, June 10, 2025 (GLOBE NEWSWIRE) -- Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced that its wholly owned subsidiary Sentinum, Inc. (“Sentinum”), has entered into a …

XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology

XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology

Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and Commercialization Agreement with Grifols, a global …

HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration

HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration

Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in their Phase Ib clinical trial of its …

[Latest] Global Neoantigen Cancer Vaccine Market Size/Share Worth USD 1.98 Billion by 2034 at a 15.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

[Latest] Global Neoantigen Cancer Vaccine Market Size/Share Worth USD 1.98 Billion by 2034 at a 15.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, June 10, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Neoantigen Cancer Vaccine Market Size, Trends and Insights By Product (Personalised antigen vaccine, Off-the-shelf neoantigen vaccine), By …

मोटापा-रोधी ओरल दवा कार्यक्रम में RenaissThera ने हासिल की शोध की अहम उपलब्धि

मोटापा-रोधी ओरल दवा कार्यक्रम में RenaissThera ने हासिल की शोध की अहम उपलब्धि

बेंगलुरु, भारत, June 10, 2025 (GLOBE NEWSWIRE) -- बेंगलुरु स्थित बायोटेक्नोलॉजी कंपनी RenaissThera प्राइवेट लिमिटेड ने अपने मोटापा रोधी दवा कार्यक्रम के तहत ग्लूकोज़-डिपेंडेंट इंस्युलिनोट्रॉपिक पोलिपेप्टाइड रिसेप्टर (GIPR) को लक्ष्य करते हुए एक महत्वपूर्ण …

Zero Trust Security Reduces Cyber Insurance Claims, Preventing up to $465 Billion Annually in Global Economic Loss from Cyber Attacks

Zero Trust Security Reduces Cyber Insurance Claims, Preventing up to $465 Billion Annually in Global Economic Loss from Cyber Attacks

Nearly a third of the cyber events encompassed by the study potentially could have been prevented if zero trust was deployed, assuming proper cyber security hygiene was also applied Companies can limit the risk of a damaging cyber incident by deploying …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service